New method to prepare autologous fibrin glue on demand

Translational Research

Volumn 149, Issue 4, 2007, Pages 187-195

  Alston, Steven M ^a   Solen, Kenneth A ^a   Broderick, Adam H ^a   Sukavaneshvar, Sivaprasad ^b   Mohammad, S Fazal ^b,c  

^a Department of Electrical and Computer Engineering   (United States)

^b Thrombodyne Inc   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; APROTININ; BLOOD CLOTTING FACTOR 13; CALCIUM; CALCIUM CHLORIDE; FIBRIN GLUE; FIBRINOGEN; PROTAMINE; SEALANT; THROMBIN;

AORTA; ARTICLE; BLOOD CLOTTING; CONCENTRATION (PARAMETERS); COW; HUMAN; METHODOLOGY; NORMAL HUMAN; PLASMA; PRECIPITATION; PRIORITY JOURNAL; TECHNIQUE; TEMPERATURE DEPENDENCE; TENSILE STRENGTH;

EID: 33947308901     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2006.08.004     Document Type: Article

References (43)

1. Jackson M.R. Fibrin sealants in surgical practice: an overview. Am J Surg 182 suppl 2 (2001) S1-S7
2. Dresdale A., Rose E.A., Jeevanandam V., Reemtsma K., Bowman F.O., and Malm J.R. Preparation of fibrin glue from single-donor fresh-frozen plasma. Surgery 97 (1985) 750-754
3. Mosesson M.W. Fibrin polymerization and its regulatory role in hemostasis. J Lab Clin Med 116 (1990) 8-17
4. Spotnitz W.D., Mintz P.D., Avery N., Bithell T.C., Kaul S., and Nolan S.P. Fibrin glue from stored human plasma: an inexpensive and efficient method for local blood bank preparation. Am Surg 53 (1987) 460-464
5. Silver F.H., Wang M.C., and Pins G.D. Preparation of fibrin glue: a study of chemical and physical methods. J Appl Biomater 6 (1995) 175-183
6. Vila V., Reganon E., Llopis F., and Aznar J. A rapid method for isolation of fibrinogen from human plasma by precipitation with polyethylene glycol 6,000. Thromb Res 39 (1985) 651-656
7. Yoshida H., Hirozane K., and Kamiya A. Comparative study of autologous fibrin glues prepared by cryo-centrifugation, cryo-filtration, and ethanol precipitation methods. Biol Pharm Bull 22 (1999) 1222-1225
8. Gammon R.R., Avery N., and Mintz P.D. Fibrin sealant: an evaluation of methods of production and the role of the blood bank. J Long Term Eff Med Implants 8 (1998) 103-116
9. Sierra D.H. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J Biomat Appl 7 (1993) 309-352
10. Park M.S., and Cha C.I. Biochemical aspects of autologous fibrin glue derived from ammonium sulfate precipitation. Laryngoscope 103 (1993) 193-196
11. Brennan M. Fibrin glue. Blood Rev 5 (1991) 240-244
12. Barker T.H., Fuller G.M., Klinger M.M., Feldman D.S., and Hagood J.S. Modification of fibrinogen with poly(ethylene glycol) and its effects on fibrin clot characteristics. J Biomed Mater Res 56 (2001) 529-535
13. Cohn S.M., Feinstein A.J., Nicholas J.M., McKenney M.A., Sleeman D., Ginzburg E., et al. Recipe for poor man's fibrin glue. J Trauma 44 (1998) 907
14. Fattahi T., Mohan M., and Caldwell G.T. Clinical applications of fibrin sealants. J Oral Maxillofac Surg 62 (2004) 218-224
15. MacGillivray T.E. Fibrin sealants and glues. J Card Surg 18 (2003) 480-485
16. Toma A.G., Fisher E.W., and Cheesman A.D. Autologous fibrin glue in the repair of dural defects in craniofacial resections. J Laryngol Otol 106 (1992) 356-357
17. Kjaergard H.K., Velada J.L., Pulawska T., Ellensen V.S., Larsen S.S., and Hollingsbee D.A. Development of a model for measurement of adhesion strength of fibrin sealant to human tissue. Eur Surg Res 31 (1999) 491-496
18. Buchta C., and Semple E. Blood bank produced fibrin sealant and bacterial contamination. Biologicals 33 (2005) 197-199
19. Ferguson J.H. The action of heparin, serum albumin (crystalline), and salmine on blood-clotting mechanisms. Am J Physiol 130 (1940) 759-770
20. Mylon E., Winternitz M.C., and Suto-Nagy G.J. The determination of fibrinogen with protamine. J Biol Chem 143 (1942) 21-27
21. Portmann A.F., and Holden W.D. Protamine (salmine) sulphate, heparin, and blood coagulation. J Clin Invest 28 (1949) 1451-1458
22. Dickneite G., Metzner H., Pfeifer T., Kroez M., and Witzke G. A comparison of fibrin sealants in relation to their in vitro and in vivo properties. Thromb Res 112 1-2 (2003) 73-82
23. Clauss A. Gerinungs physiologische schnell methods zur bestimmung des fibrinogens. Acta Haematol 17 (1957) 237
24. Nowotny R., Chalupka A., Nowotny C., and Bosch P. Preparation of fibrin clot samples for tensile stress-strain testing. Biomaterials 2 (1981) 55-56
25. Guyton A.C., and Hall J.E. Textbook of medical physiology. 9th ed. (1996), W. B. Saunders Company, Philadelphia, PA
26. Marx G., and Blankenfeld A. Kinetic and mechanical parameters of pure and cryoprecipitate fibrin. Blood Coagul Fibrinolysis 4 (1993) 73-78
27. Mintz P.D., Mayers L., Avery N., Flanagan H.L., Burks S.G., and Spotnitz W.D. Fibrin sealant: clinical use and the development of the University of Virginia Tissue Adhesive Center. Ann Clin Lab Sci 31 (2001) 108-118
28. Siedentop K.H., Park J.J., and Sanchez B. An autologous fibrin tissue adhesive with greater bonding power. Arch Otolaryngol Head Neck Surg 121 (1995) 769-772
29. Bale M.D., and Mosher D.F. Thrombospondin is a substrate for blood coagulation factor XIIIa. Biochemistry 25 (1986) 5667-5673
30. Hada M., Kaminski M., Bockenstedt P., and McDonagh J. Covalent crosslinking of von Willebrand factor to fibrin. Blood 68 (1986) 95-101
31. Hansen M.S. Fibronectin and coagulation factor XIII increases blood platelet adhesion to fibrin. Thromb Res 34 (1984) 551-556
32. Buchta C., Dettke M., Funovics P.T., Höcker P., Knöbl P., Macher M., et al. Fibrin sealant produced by the CryoSeal FS System: product chemistry, material properties and possible preparation in the autologous preoperative setting. Vox Sanguinis 86 (2004) 257-262
33. Spotnitz W.D. Fibrin sealant in the United States: clinical use at the University of Virginia. Thromb Haemost 74 (1995) 482-485
34. Marx G., and Mou X. Characterizing fibrin glue performance as modulated by heparin, aprotinin, and factor XIII. J Lab Clin Med 140 (2002) 152-160
35. Phillips M., Dickneite G., and Metzner H. Fibrin sealants in supporting surgical techniques: strength in factor XIII. Cardiovasc Surg 11 suppl 1 (2003) 13-16
36. Dickneite G., Metzner H.J., Kroez M., Hein B., and Nicolay U. The importance of factor XIII as a component of fibrin sealants. J Surg Res 107 (2002) 186-195
37. Summary Basis for Approval, Fibrin Sealant - Tisseel VH Kit. Available at: www.fda.gov/cber/sba/fiboih050198sba.pdf.
38. Velada J.L., Hollingsbee D.A., Menzies A.R., Cornwell R., and Dodd R.A. Reproducibility of the mechanical properties of Vivostat system patient-derived fibrin sealant. Biomaterials 23 (2002) 2249-2254
39. Balleisen L., Bailey J., Epping P.H., Schulte H., and van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: 1. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 54 (1985) 475-479
40. Lee A.J., Lowe G.D., Woodward M., and Tunstall-Pedoe H. Fibrinogen in relation to personal history of prelevant hypertension, diabetes, stroke, intermittent claudication, coronary heart disease and family history: the scottish heart health study. Br Heart J 69 (1993) 338-342
41. Lip G.Y.H. Fibrinogen and cardiovascular disorders. Q J Med 88 (1995) 155-165
42. Tarallo P., Henny J., Gueguen R., and Siest G. Reference limits of plasma fibrinogen. Eur J Clin Chem Clin Biochem 30 (1992) 745-751
43. Casali B., Rodeghiero F., Tosetto A., Palmieri B., Immovilli R., Ghedini C., et al. Fibrin glue from single-donation autologous plasmapheresis. Transfusion 32 (1992) 641-643